Read + Share
Amedeo Smart
Independent Medical Education
Ageno W, Bertu L, Bucherini E, Camporese G, et al. Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ 2022;379:e072623.PMID: 36520715
Email
LinkedIn
Facebook
Twitter
Privacy Policy